Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.67
-0.43 (-10.49%)
At close: Aug 14, 2025, 3:59 PM
3.67
0.00%
Pre-market: Aug 15, 2025, 07:21 AM EDT

Oncology Institute Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
393.41M 324.24M 252.48M 203M
Cost of Revenue
339.42M 264.67M 200.39M 162.16M
Gross Profit
54M 59.57M 52.09M 40.85M
Operating Income
-60.12M -77.02M -81.95M -45.86M
Interest Income
n/a n/a n/a n/a
Pretax Income
-64.66M -83.1M -91K -11.6M
Net Income
-64.66M -83.07M 152K -10.93M
Selling & General & Admin
107.83M 113.85M 119.69M 83.36M
Research & Development
n/a n/a n/a n/a
Other Expenses
6.29M 22.74M 4.41M 3.34M
Operating Expenses
114.11M 136.59M 124.1M 86.71M
Interest Expense
7.5M 6.78M 4.08M 320K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
453.53M 401.26M 334.43M 248.86M
Income Tax Expense
n/a -36K -243K -671K
Shares Outstanding (Basic)
75.04M 73.75M 72.79M 66.23M
Shares Outstanding (Diluted)
75.04M 73.75M 80.61M 66.23M
EPS (Basic)
-0.71 -0.92 0.00 -0.16
EPS (Diluted)
-0.71 -0.92 -0.21 -0.16
EBITDA
-50.88M -70.45M 8.4M -7.94M
EBIT
-57.17M -76.33M 3.99M -11.28M
Depreciation & Amortization
6.29M 5.87M 4.41M 3.34M